Comparative Analysis of Prostate-Specific Membrane Antigen (PSMA) Versus a Prostate-Specific Membrane Antigen-Like Gene

Prostate

Volumn 58, Issue 2, 2004, Pages 200-210

  O'Keefe, Denise S ^b   Bacich, Dean J ^b   Heston, Warren D W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Cancer; Folate hydrolase; Naaladase; Therapeutics; Tumor vasculature

Indexed keywords

CAPROMAB PENDETIDE IN 111; COMPLEMENTARY DNA; LUCIFERASE; MESSENGER RNA; MONOCLONAL ANTIBODY; NUCLEOTIDE; PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA LIBRARY; DNA PROBE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; METASTASIS; MOLECULAR CLONING; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SEQUENCE HOMOLOGY; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, SURFACE; BASE SEQUENCE; BLOTTING, NORTHERN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; INDIUM RADIOISOTOPES; MALE; MOLECULAR SEQUENCE DATA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0742270342     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10319     Document Type: Article

References (34)

1. McDevitt MR, Ma D, Lai LT, Simon J, Borchardt P, Frank RK, Wu K, Pellegrini V, Curcio MJ, Miederer M, Bander NH, Scheinberg DA. Tumor therapy with targeted atomic nanogenerators. Science 2001;294:1537-1540.
2. Wright GL Jr, Haley C, Beckett ML, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign and malignant prostate tissues. Urol Oncol 1995;1:18-28.
3. Kawakami M, Nakayama J. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res 1997;57:2321-2324.
4. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 1997;3:81-85.
5. Israeli RS, Powell CT, Fair WR, Heston WD. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 1993;53:227-230.
6. Liu H, Moy P, Kim S, Xia Y, Rajasekaran A, Navarro V, Knudsen B, Bander NH. Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium. Cancer Res 1997;57:3629-3634.
7. Chang SS, O'Keefe DS, Bacich DJ, Reuter VE, Heston WD, Gaudin PB. Prostate-specific membrane antigen is produced in tumor-associated neovasculature. Clin Cancer Res 1999;5:2674-2681.
8. Tjoa BA, Simmons SJ, Elgamal A, Rogers M, Ragde H, Kenny GM, Troychak MJ, Boynton AL, Murphy GP. Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate 1999;40:125-129.
9. Theodorescu D, Frierson HF Jr, Sikes RA. Molecular determination of surgical margins using fossa biopsies at radical prostatectomy. J Urol 1999;161:1442-1448.
10. Bander NH. PSMA as a therapeutic target. In: AACR 93rd Annual Meeting, San Francisco, CA, 2002.
11. Luthi-Carter R, Barczak AK, Speno H, Coyle JT. Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther 1998;286:1020-1025.
12. Murphy GP, Su S, Jarisch J, Kenny GM. Serum levels of PSMA. Prostate 2000;42:318-319.
13. O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WD. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta 1998;1443:113-127.
14. Zhang J, Qin S, Sait SN, Haley LL, Henry WM, Higgins MJ, Nowak NJ, Shows TB, Gerhard DS. The pericentromeric region of human chromosome 11: Evidence for a chromosome-specific duplication. Cytogenet Cell Genet 2001;94:137-141.
15. Ausubel FM. Short protocols in molecular biology, 3rd edn. New York, NY: John Wiley and Sons, Inc.; 1992.
16. Su SL, Huang IP, Fair WR, Powell CT, Heston WD. Alternatively spliced variants of prostate-specific membrane antigen RNA: Ratio of expression as a potential measurement of progression. Cancer Res 1995;55:1441-1443.
17. O'Keefe DS, Uchida A, Bacich DJ, Watt FB, Martorana A, Molloy PL, Heston WD. Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer. Prostate 2000;45:149-157.
18. Troyer JKF, Q. Beckett ML, Wright GL Jr. Biochemical characterization and mapping of the 7E11C5.3 epitope of the prostate-specific membrane antigen. Urol Oncol 1995;1:29-37.
19. Watt F, Martorana A, Brookes DE, Ho T, Kingsley E, O'Keefe DS, Russell PJ, Heston WD, Molloy PL. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics 2001;73:243-254.
20. O'Keefe DS, Bacich DJ, Horiguchi Y, Nowak NJ, Fair WR, Heston WDW. Mapping, genomic organization and promoter analysis of the prostate specific membrane antigen gene. In: Proceedings of new research approaches in the prevention and cure of pro state cancer. 10th anniversary of the AACR special conferences in cancer research., Indian Wells, CA., December 2-6, 1998.
21. Bacich DJP, J.T. Tong WP, Heston WDW. Cloning, expression, genomic localization and enzymatic activities of the murine homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm Genome 2001;12:117-123.
22. Tsai G, Passani LA, Slusher BS, Carter R, Baer L, Kleinman JE, Coyle JT. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995;52:829-836.
23. Pangalos MN, Neefs JM, Somers M, Verhasselt P, Bekkers M, van der Helm L, Fraiponts E, Ashton D, Gordon RD. Isolation and expression of novel human glutamate carboxypeptidases with N-acetylated alpha-linked acidic dipeptidase and dipeptidyl peptidase IV activity. J Biol Chem 1999;274:8470-8483.
24. Shneider BL, Thevananther S, Moyer MS, Walters HC, Rinaldo P, Devarajan P, Sun AQ, Dawson PA, Ananthanarayanan M. Cloning and characterization of a novel peptidase from rat and human ileum. J Biol Chem 1997;272:31006-31015.
25. Uchida A, O'Keefe DS, Bacich DJ, Molloy PL, Heston WD. In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: A potential alternative approach to androgen deprivation therapy. Urology 2001;58:132-139.
26. Kaffer CR, Srivastava M, Park KY, Ives E, Hsieh S, Batlle J, Grinberg A, Huang SP, Pfeifer K. A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev 2000;14:1908-1919.
27. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD. Expression of the prostate-specific membrane antigen. Cancer Res 1994;54:1807-1811.
28. Barinka C, Rinnova M, Sacha P, Rojas C, Majer P, Slusher BS, Konvalinka J. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J Neurochem 2002;80:477-487.
29. Ghosh A, Heston WDW. Effect of carbohydrate moieties on the enzyme activity of the prostate specific membrane antigen (PSMA)/folate hydrolase/glutamate carboxypeptidase II, Prostate 2003;57:140-151.
30. Tasch J, Gong M, Sadelain M, Heston WD. A unique folate hydrolase, prostate-specific membrane antigen (PSMA): A target for immunotherapy? Crit Rev Immunol 2001;21:249-261.
31. Milowsky MI, Rosmarin AS, Cobham MV, Navarro MV, Keresztes RS, Kostakoglu L, Smith-Jones PM, Vallabhajosula S, Kim SW, Liu H, Goldsmith SJ, Bander NH, Nanus DM. Anti-PSMA mAb huJ591 specifically targets tumor vascular endothelial cells in patients with advanced solid tumor malignancies. In: ASCO Annual Meeting, Orlando, FL, 2002.
32. 177Lu) in advanced prostate cancer (Pca). In: ASCO Annual Meeting, Orlando, FL, 2002.
33. Bander N. Prostate specific membrane antigen (PSMA) as a therapeutic target. In: New discoveries in prostate cancer biology and treatment, Naples, FL, 2001.
34. Murphy GP, Tjoa BA, Simmons SJ, Ragde H, Rogers M, Elgamal A, Kenny GM, Troychak MJ, Salgaller ML, Boynton AL. Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 1999;39:54-59.